Skip to main content
SpringerLink
Log in

Vasoactive Effects of Estrogens

  • Chapter
Women’s Health in Menopause

Part of the book series: Medical Science Symposia Series ((MSSS,volume 7))

  • 104 Accesses

Abstract

Actions of estrogens in the walls of arteries have atherosclerotic-inhibiting and hemodynamic effects. Because others participating in this Symposium will be directly addressing the role of estrogens in preventing atherosclerotic cardiovascular disease, this presentation will focus on the hemodynamic effects of ovarian hormones.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Magness RR, Rosenfeld CR. Local and systemic estradiol-17β: effects on uterine and systemic vasodilation. Am J Physiol 1989;256(Endocrinol Metab 19):E536–E542.

    PubMed  CAS  Google Scholar 

  2. Sarrel PM. Ovarian hormones and the circulation. Maturitas 1990;12:287–98.

    Article  PubMed  CAS  Google Scholar 

  3. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373–76.

    Article  PubMed  CAS  Google Scholar 

  4. Henderson AH. Endothelium in control. Br Heart J 1991;65:116–25.

    Article  PubMed  CAS  Google Scholar 

  5. Pohl U, Busse R, Kuon E, Bassenge E. Pulsatile perfusion stimulates the release of endothelial autocoids. J Appl Cardiol 1986;1:215–35.

    CAS  Google Scholar 

  6. Edwards DH, Griffith TM, Ryley HC, Henderson AH. Haptoglobinhaemoglobin complex in human plasma inhibits endothelium-dependent relaxation: evidence that endothelium derived relaxing factor acts as a local autocoid. Cardiovasc Res 1986;20:549–56.

    Article  PubMed  CAS  Google Scholar 

  7. Collins P, Burman J, Chung H-I, Fox K. Hemoglobin inhibits endothelium-dependent relaxation to acetylcholine in human coronary arteries in vivo. Circulation 1993;87:80–85.

    Article  PubMed  CAS  Google Scholar 

  8. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524–26.

    Article  PubMed  CAS  Google Scholar 

  9. Myers PR, Minor RL, Guerra, Jr R, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine that nitric oxide. Nature 1990;345:161–3.

    Article  PubMed  CAS  Google Scholar 

  10. Griffith TM, Henderson AH. EDRF and the regulation of vascular tone. Int J Microcirc 1989;8:383–96.

    CAS  Google Scholar 

  11. Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411–15.

    Article  PubMed  CAS  Google Scholar 

  12. Luscher TF, Yang Z, Tschudi M et al. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 1990;66:1088–94.

    Article  PubMed  CAS  Google Scholar 

  13. McEwen BS. Non-genomic and genomic effects of steroids on neural activity. TIPS 1991;12:141–47.

    PubMed  CAS  Google Scholar 

  14. Kronenberg F, Cote LI, Linki DM, Dyrenfurth I, Downey JA. Menopausal hot flushes: thermoregulatory, cardiovascular and circulating catecholamine and LH changes. Maturitas 1984:6;31–43.

    Article  PubMed  CAS  Google Scholar 

  15. Hamlet MA, Rorie DK, Tyce GM. Effects of estradiol on release and disposition of norepinephrine from nerve endings. Am J Physiol 1980;239:H450–H456.

    PubMed  CAS  Google Scholar 

  16. Spaziani E, Szengo CM. Further evidence for mediation by histamine of estrogenic stimulation of the rat uterus. Endocrinology 1959;64:713–23.

    Article  PubMed  CAS  Google Scholar 

  17. Kahlson G, Rosengren E. Physiology of histamine. Am J Physiol 1968;48:181–82.

    Google Scholar 

  18. Horwitz KB, Horwitz LD. Canine vascular tissues are targets for androgens, estrogens, progestins and glucocorticoids. J Clin Invest 1982;69:750–58.

    Article  PubMed  CAS  Google Scholar 

  19. Nakao J et al. Estradiol-binding sites in rat aortic smooth muscle cells in culture. Atherosclerosis 1981;38:75–80.

    Article  PubMed  CAS  Google Scholar 

  20. Campisi D et al. Oestrogen binding sites in fresh human aortic tissue. Int J Tiss React 1987;IX(5):393–98.

    Google Scholar 

  21. Padwick ML et al. Demonstration of oestrogen receptor related protein in female tissues. In: Studd JWW, Whitehead MI, editors. The Menopause. Oxford: Blackwell Scientific Press, 1988:227–33.

    Google Scholar 

  22. Ingegno MD, Money SR, Thelmo W et al. Progesterone receptors in the human heart and great vessels. Lab Invest 1988;59:353–56.

    PubMed  CAS  Google Scholar 

  23. Penny LL, Frederick RJ, Parker GW. 17-βestradiol stimulation of uterine blood flow in oophorectomized rabbits with complete inhibition of uterine ribonucleic acid synthesis. Endocrinol 1981;109:1672–76.

    Article  Google Scholar 

  24. Williams JK, Adams MR, Klopfenstein S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680–87.

    Article  PubMed  CAS  Google Scholar 

  25. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992;20:452–57.

    Article  PubMed  CAS  Google Scholar 

  26. Van Buren G, Yang D, Clark ICE. Estrogen-induced uterine vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 1992;16:828–33.

    Google Scholar 

  27. Collins P, Rosano GMC, Adamopoulos S et al. Reversal of acetylcholine-induced vasoconstriction by intracoronary administration of estradiol-17βin menopausal women with coronary artery disease. Circulation 1993; 88:I-589.

    Google Scholar 

  28. Shay J, Badrov N, Attele A, Levinson M, Moss J. Estrogen antagonizes endothelin-1 vasoconstriction in rabbit basilar artery. Anesth Analg 1993;A561.

    Google Scholar 

  29. Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effects of 17β-estradiol on rabbit coronary responses to endothelin-1. Am J Physiol 1992;263(Heart Circ Physiol 32):H271–H275.

    PubMed  CAS  Google Scholar 

  30. Polderman KH, Stehouwer CDA, van Kamp GJ, Dekker GA, Verheugt FWA, Gooren LJG. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 1993;118:429–32.

    PubMed  CAS  Google Scholar 

  31. Collins P, Rosano GMC, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Cardiovascular protection by oestrogen-a calcium antagonist effect? Lancet 1993; 341:1264–65.

    Article  PubMed  CAS  Google Scholar 

  32. Harder DR, Coulson PB. Estrogen receptors and effects of estrogen on membrane electrical properties of coronary smooth muscle. J Cell Physiol 1979;100:375–82.

    Article  PubMed  CAS  Google Scholar 

  33. Stice SL, Ford SP, Rosazza JP, Van-Orden DE. Role of 4-hydoxylated estradiol in reducing Ca++ uptake of uterine smooth muscle cells through potential-sensitive channels. Biol Reprod 1987;36:361–68.

    Article  PubMed  CAS  Google Scholar 

  34. Downing SJ, Hollingsworth M, Miller M. The influence of oestrogen and progesterone on the actions of two calcium entry blockers in the rat uterus. J Endocrinol 1988;118:251–58.

    Article  PubMed  CAS  Google Scholar 

  35. Jiang C, Poole-Wilson PA, Sarrel PM, Mochizuki S, Collins P, MacLeod KT. Effect of 17β-Estradiol on contraction, Ca++ current and intracellular free Ca++ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 1992;106:793–45.

    Article  Google Scholar 

  36. Chester A, Jiang C, Sarrel PM, Borland J, Yacoub M, Collins P. 17β-Estradiol induces endothelium-independent relaxation in human coronary arteries in vitro. Circulation 1993;88:I-79.

    Google Scholar 

  37. Mugge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. Endothelium-independent relaxation of human coronary arteries by 17β-estradiol in vitro. Cardiovascular Research 1993, in press.

    Google Scholar 

  38. Altura BM. Sex as a factor influencing the responsiveness of arterioles to catecholamines. Eur J Pharmacol 1982;20:281.

    Google Scholar 

  39. Davidson L, Rouse IL, Vandongen R, Beilin II. Plasma noradrenaline and its relationship to plasma estradiol in normal women during the menstrual cycle. Clin and Exp Pharm & Physio 1985;12:489–93.

    Article  CAS  Google Scholar 

  40. Haigh Al, Lloyd S, Pickford M. A relationship between adrenaline and the mode of action of oxytocin and oestrogen on vascular smooth muscle. J Physiol London 1962;178:563–76.

    Google Scholar 

  41. Hamlet MA, Rorie DK, Tyce GM. Effects of estradiol on release and disposition of norepinephrine from nerve endings. Am J Physiol 1980;239:H450–H456.

    PubMed  CAS  Google Scholar 

  42. Kronenberg F, Cote LI, Linki DM, Dyrenfurth I, Downey JA. Menopausal hot flushes: thermoregulatory, cardiovascular and circulating catecholamine and LH changes. Maturitas 1984:6;31–43.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut, 06510, USA

    Philip M. Sarrel

Authors
  1. Philip M. Sarrel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Milan, Milan, Italy

    P. G. Crosignani

  2. Institute of Pharmacological Sciences, University of Milan, Milan, Italy

    R. Paoletti

  3. Department of Obstetrics and Gynecology, Yale University, School of Medicine, New Haven, Connecticut, USA

    P. M. Sarrel

  4. Department of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA

    N. K. Wenger

  5. Clinica Menopausa, Milan, Italy

    M. Meschia (Assistant Editor) (Assistant Editor)

  6. Institute of Pharmacological Sciences, University of Milan, Milan, Italy

    M. Soma (Assistant Editor) (Assistant Editor)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Sarrel, P.M. (1994). Vasoactive Effects of Estrogens. In: Crosignani, P.G., Paoletti, R., Sarrel, P.M., Wenger, N.K., Meschia, M., Soma, M. (eds) Women’s Health in Menopause. Medical Science Symposia Series, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1024-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-1024-2_17

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4446-2

  • Online ISBN: 978-94-011-1024-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation